logo

For the Inventor, By the Inventor

Kendall Park, NJ, United States of America

David Rosen

This inventor holds 9 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Ligand Pharmaceuticals, Inc., Bayer Cropscience Ag, Fmc Corporation. Active years: 2007-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Rosen. Retrieved from https://idiyas.com/inventor/david-rosen-6qa6bm7e

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7

 

Average Co-Inventor Count = 12.2

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:

goldMedal5 out of 139 
 
Ligand Pharmaceuticals, Inc.
 patents
silverMedal2 out of 1,036 
 
Bayer Cropscience Ag
 patents
bronzeMedal2 out of 2,517 
 
Fmc Corporation
 patents

Years Active: 2007-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 11773110 - Heterocycle amines and uses thereof (2023-10-03),
2. 11186593 - Heterocycle amines and uses thereof (2021-11-30),
3. 10604533 - Heterocycle amines and uses thereof (2020-03-31),
4. 10030034 - Heterocycle amines and uses thereof (2018-07-24),
5. 9266874 - Heterocycle amines and uses thereof (2016-02-23),
6. 8119563 - N-substituted azacycles (2012-02-21),
7. 7683070 - N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines (2010-03-23),
8. 7365082 - N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines (2008-04-29),
9. 7300946 - N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines (2007-11-27),

Title: Innovations by David Rosen: A Leader in Heterocycle Amines

Introduction

David Rosen, a prolific inventor based in Kendall Park, NJ, has made significant contributions to the fields of chemistry and medicine. With a remarkable portfolio of nine patents, Rosen has focused on advancing the science behind heterocycle amines and their applications in treating inflammatory disorders.

Latest Patents

Rosen's latest patents revolve around "Heterocycle Amines and Uses Thereof." The patents detail various compounds, compositions, and methods that harness the potential of heterocycle amines. These innovations aim to provide new therapeutic options for managing and treating inflammatory disorders, showcasing Rosen's commitment to medical advancement.

Career Highlights

Throughout his career, David Rosen has worked with reputable companies in the pharmaceutical industry, including Ligand Pharmaceuticals, Inc. and FMC Corporation. His experience in these organizations has enriched his expertise in the application of chemistry to solve complex medical challenges.

Collaborations

Rosen’s collaborative spirit is evident through his work alongside esteemed colleagues such as Koc-Kan Ho and David J. Diller. These collaborations have fostered an environment of innovation, enabling the development of groundbreaking solutions in the realm of medicinal chemistry.

Conclusion

In conclusion, David Rosen's contributions to the fields of chemistry and medicine through his innovative patents reflect his dedication to improving healthcare. His ongoing research and collaboration with industry leaders position him as a significant figure in the pursuit of new treatments for inflammatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…